The Claim
In HT29 colon cancer cells, exposure to low glucose (1.1 mM) reduces mitochondrial-derived ATP by approximately 20% compared to normal glucose (16.6 mM), while glycolytic ATP increases by 15–20%, indicating a metabolic shift toward glycolysis under glucose stress.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When HT29 colon cancer cells are exposed to low glucose, their mitochondrial ATP production decreases by about 20%, and their glycolytic ATP production increases by 15–20%, resulting in a measurable shift from mitochondrial energy production to glycolysis.
See the scientific wording
In HT29 colon cancer cells, low glucose (1.1 mM) reduces mitochondrial-derived ATP by approximately 20% compared to normal glucose (16.6 mM), while glycolytic ATP increases by 15–20%, indicating a metabolic shift toward glycolysis under glucose stress.
When sugar levels drop, cells stop using their mitochondria to make energy because there isn't enough sugar to feed them. Instead, they break down sugar in a different way inside the cell fluid to keep making energy. A backup system kicks in to recycle a molecule called malate into pyruvate, which keeps the sugar-breaking process going and maintains the cell's energy balance, even though the mitochondria can't make as much energy anymore.
What the research says
1 studyWhen colon cancer cells don’t get enough sugar, they stop using their mitochondria to make energy and switch to making energy the simpler, sugar-based way—like switching from a fancy engine to a basic bicycle.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.